abstract |
Systems and methods are provided for determining relevant medical information about a cancer based on the distribution of fragment lengths of cell-free DNA sequenced from a biological fluid sample. In certain embodiments, the systems and methods are useful for segmenting a cancer genome, phasing alleles in a cancer genome, detecting the loss of heterozygosity in a cancer genome, assigning an origin of a variant allele, validating a sequencing mapping, and validating use of an allele in a cancer classifier. |